Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Jon Laman

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Molecular Sequence Data

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Kappen Jasper H; Wallace Graham R; Stolk Lisette; Rivadeneira Fernando; Uitterlinden Andre G; van Daele Paul L A; Laman Jon D; Kuijpers Robert W A M; Baarsma Goitze Seerp; Stanford Miles R; Fortune Farida; Madanat Wafa; van Hagen Petrus Martin; van Laar Jan A M
Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.
van Velzen Monique; Laman Jon D; Kleinjan Alex; Poot Angelique; Osterhaus Albert D M E; Verjans Georges M G M
Neuron-interacting satellite glial cells in human trigeminal ganglia have an APC phenotype.
't Hart Bert A; Hintzen Rogier Q; Laman Jon D
Multiple sclerosis - a response-to-damage model.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Jon Laman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Kappen Jasper H; Wallace Graham R; Stolk Lisette; Rivadeneira Fernando; Uitterlinden Andre G; van Daele Paul L A; Laman Jon D; Kuijpers Robert W A M; Baarsma Goitze Seerp; Stanford Miles R; Fortune Farida; Madanat Wafa; van Hagen Petrus Martin; van Laar Jan A M
Low prevalence of NOD2 SNPs in Behçet's disease suggests protective association in Caucasians.
Rheumatology (Oxford, England) 2009;48(11):1375-7.
2009: van Velzen Monique; Laman Jon D; Kleinjan Alex; Poot Angelique; Osterhaus Albert D M E; Verjans Georges M G M
Neuron-interacting satellite glial cells in human trigeminal ganglia have an APC phenotype.
Journal of immunology (Baltimore, Md. : 1950) 2009;183(4):2456-61.
2009: 't Hart Bert A; Hintzen Rogier Q; Laman Jon D
Multiple sclerosis - a response-to-damage model.
Trends in molecular medicine 2009;15(6):235-44.
2009: van der Fits Leslie; Mourits Sabine; Voerman Jane S A; Kant Marius; Boon Louis; Laman Jon D; Cornelissen Ferry; Mus Anne-Marie; Florencia Edwin; Prens Errol P; Lubberts Erik
Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23/IL-17 axis.
Journal of immunology (Baltimore, Md. : 1950) 2009;182(9):5836-45.
2009: van Zwam Marloes; Huizinga Ruth; Melief Marie-José; Wierenga-Wolf Annet F; van Meurs Marjan; Voerman Jane S; Biber Knut P H; Boddeke Hendrikus W G M; Höpken Uta E; Meisel Christian; Meisel Andreas; Bechmann Ingo; Hintzen Rogier Q; 't Hart Bert A; Amor Sandra; Laman Jon D; Boven Leonie A
Brain antigens in functionally distinct antigen-presenting cell populations in cervical lymph nodes in MS and EAE.
Journal of molecular medicine (Berlin, Germany) 2009;87(3):273-86.
2009: van Zwam Marloes; Huizinga Ruth; Heijmans Nicole; van Meurs Marjan; Wierenga-Wolf Annet F; Melief Marie-José; Hintzen Rogier Q; 't Hart Bert A; Amor Sandra; Boven Leonie A; Laman Jon D
Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
The Journal of pathology 2009;217(4):543-51.
2008: Segers Dolf; Garcia-Garcia Hector M; Cheng Caroline; de Crom Rini; Krams Rob; Wentzel Jolanda J; van der Steen Anton F W; Serruys Patrick W; Leenen Pieter J M; Laman Jon D
A primer on the immune system in the pathogenesis and treatment of atherosclerosis.
EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology 2008;4(3):378-90.
2008: Wolf Maarten G; Jongejan Jaap A; Laman Jon D; de Leeuw Simon W
Quantitative prediction of amyloid fibril growth of short peptides from simulations: calculating association constants to dissect side chain importance.
Journal of the American Chemical Society 2008;130(47):15772-3.
2008: Wolf Maarten G; Jongejan Jaap A; Laman Jon D; de Leeuw Simon W
Rapid free energy calculation of peptide self-assembly by REMD umbrella sampling.
The journal of physical chemistry. B 2008;112(43):13493-8.
2008: Jagessar S Anwar; Smith Paul A; Blezer Erwin; Delarasse Cecile; Pham-Dinh Danielle; Laman Jon D; Bauer Jan; Amor Sandra; 't Hart Bert
Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
Journal of neuropathology and experimental neurology 2008;67(4):326-40.
2008: Kap Yolanda S; Smith Paul; Jagessar S Anwar; Remarque Ed; Blezer Erwin; Strijkers Gustav J; Laman Jon D; Hintzen Rogier Q; Bauer Jan; Brok Herbert P M; 't Hart Bert A
Fast progression of recombinant human myelin/oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis in marmosets is associated with the activation of MOG34-56-specific cytotoxic T cells.
Journal of immunology (Baltimore, Md. : 1950) 2008;180(3):1326-37.
2008: 't Hart Bert A; Hintzen Rogier Q; Laman Jon D
Preclinical assessment of therapeutic antibodies against human CD40 and human interleukin-12/23p40 in a nonhuman primate model of multiple sclerosis.
Neuro-degenerative diseases 2008;5(1):38-52.
2007: Geleijns Karin; Emonts Marieke; Laman Jon D; van Rijs Wouter; van Doorn Pieter A; Hermans Peter W M; Jacobs Bart C
Genetic polymorphisms of macrophage-mediators in Guillain-Barré syndrome.
Journal of neuroimmunology 2007;190(1-2):127-30.
2007: van Breemen Mariëlle J; de Fost Maaike; Voerman Jane S A; Laman Jon D; Boot Rolf G; Maas Mario; Hollak Carla E M; Aerts Johannes M; Rezaee Farhad
Increased plasma macrophage inflammatory protein (MIP)-1alpha and MIP-1beta levels in type 1 Gaucher disease.
Biochimica et biophysica acta 2007;1772(7):788-96.
2007: Verjans Georges M G M; Hintzen Rogier Q; van Dun Jessica M; Poot Angelique; Milikan Johannes C; Laman Jon D; Langerak Anton W; Kinchington Paul R; Osterhaus Albert D M E
Selective retention of herpes simplex virus-specific T cells in latently infected human trigeminal ganglia.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(9):3496-501.
2007: van de Geijn F E; Roos A; de Man Y A; Laman J D; de Groot C J M; Daha M R; Hazes J M W; Dolhain R J E M
Mannose-binding lectin levels during pregnancy: a longitudinal study.
Human reproduction (Oxford, England) 2007;22(2):362-71.
2007: Brok Herbert P M; Boven Leonie; van Meurs Marjan; Kerlero de Rosbo Nicole; Celebi-Paul Liesbeth; Kap Yolanda S; Jagessar Anwar; Hintzen Rogier Q; Keir Geoff; Bajramovic Jeffrey; Ben-Nun Avraham; Bauer Jan; Laman Jon D; Amor Sandra; 't Hart Bert A
The human CMV-UL86 peptide 981-1003 shares a crossreactive T-cell epitope with the encephalitogenic MOG peptide 34-56, but lacks the capacity to induce EAE in rhesus monkeys.
Journal of neuroimmunology 2007;182(1-2):135-52.
2006: Visser Lizette; Melief Marie-José; van Riel Debby; van Meurs Marjan; Sick Ella A; Inamura Seiichi; Bajramovic Jeffrey J; Amor Sandra; Hintzen Rogier Q; Boven Leonie A; 't Hart Bert A; Laman Jon D
Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates.
The American journal of pathology 2006;169(5):1671-85.
2006: Geleijns Karin; Roos Anja; Houwing-Duistermaat Jeanine J; van Rijs Wouter; Tio-Gillen Anne P; Laman Jon D; van Doorn Pieter A; Jacobs Bart C
Mannose-binding lectin contributes to the severity of Guillain-Barré syndrome.
Journal of immunology (Baltimore, Md. : 1950) 2006;177(6):4211-7.
2006: Baker B S; Laman J D; Powles A; van der Fits L; Voerman J S A; Melief M-J; Fry L
Peptidoglycan and peptidoglycan-specific Th1 cells in psoriatic skin lesions.
The Journal of pathology 2006;209(2):174-81.
2006: Damen Gerard M; Hol Jeroen; de Ruiter Lilian; Bouquet Jan; Sinaasappel Maarten; van der Woude Janneke; Laman Jon D; Hop Wim C J; Büller Hans A; Escher Johanna C; Nieuwenhuis Edward E S
Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn disease.
Journal of pediatric gastroenterology and nutrition 2006;42(2):142-9.
2006: Boven Leonie A; Van Meurs Marjan; Van Zwam Marloes; Wierenga-Wolf Annet; Hintzen Rogier Q; Boot Rolf G; Aerts Johannes M; Amor Sandra; Nieuwenhuis Edward E; Laman Jon D
Myelin-laden macrophages are anti-inflammatory, consistent with foam cells in multiple sclerosis.
Brain : a journal of neurology 2006;129(Pt 2):517-26.
2005: 't Hart Bert A; Brok Herbert P M; Remarque Ed; Benson Jacqueline; Treacy George; Amor Sandra; Hintzen Rogier Q; Laman Jon D; Bauer Jan; Blezer Erwin L A
Suppression of ongoing disease in a nonhuman primate model of multiple sclerosis by a human-anti-human IL-12p40 antibody.
Journal of immunology (Baltimore, Md. : 1950) 2005;175(7):4761-8.
2005: Zhang Yinong; van der Fits Leslie; Voerman Jane S; Melief Marie-Jose; Laman Jon D; Wang Mu; Wang Haitao; Wang Minhui; Li Xinna; Walls Chad D; Gupta Dipika; Dziarski Roman
Identification of serum N-acetylmuramoyl-l-alanine amidase as liver peptidoglycan recognition protein 2.
Biochimica et biophysica acta 2005;1752(1):34-46.
2005: 't Hart Bert A; Blezer Erwin L A; Brok Herbert P M; Boon Louis; de Boer Mark; Bauer Jan; Laman Jon D
Treatment with chimeric anti-human CD40 antibody suppresses MRI-detectable inflammation and enlargement of pre-existing brain lesions in common marmosets affected by MOG-induced EAE.
Journal of neuroimmunology 2005;163(1-2):31-9.
2005: Geleijns Karin; Laman Jon D; van Rijs Wouter; Tio-Gillen Anne P; Hintzen Rogier Q; van Doorn Pieter A; Jacobs Bart C
Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barre syndrome.
Journal of neuroimmunology 2005;161(1-2):183-9.
2005: De Vos Alex F; van Riel Debby A J; van Meurs Marjan; Brok Herbert P M; Boon Louis; Hintzen Rogier Q; Claassen Eric; 't Hart Bert A; Laman Jon D
Severe T-cell depletion from the PALS leads to altered spleen composition in common marmosets with experimental autoimmune encephalomyelitis (EAE).
Journal of neuroimmunology 2005;161(1-2):29-39.
2005: van Beek Johan; van Meurs Marjan; 't Hart Bert A; Brok Herbert P M; Neal Jim W; Chatagner Alexandra; Harris Claire L; Omidvar Nader; Morgan B Paul; Laman Jon D; Gasque Philippe
Decay-accelerating factor (CD55) is expressed by neurons in response to chronic but not acute autoimmune central nervous system inflammation associated with complement activation.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(4):2353-65.
2005: Carotenuto Patrizia; van Riel Debby; Artsen André; Bruijns Sven; Uytdehaag Fons G; Laman Jon D; van Nunen Andeltje B; Zondervan Pieter E; De Man Robert A; Osterhaus Albert D; Pontesilli Oscar
Antiviral treatment with alpha interferon up-regulates CD14 on liver macrophages and its soluble form in patients with chronic hepatitis B.
Antimicrobial agents and chemotherapy 2005;49(2):590-9.
2005: Geleijns K; Schreuder G M Th; Jacobs B C; Sintnicolaas K; van Koningsveld R; Meulstee J; Laman J D; van Doorn P A
HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome.
Neurology 2005;64(1):44-9.
2005: Visser Lizette; Jan de Heer Hendrik; Boven Leonie A; van Riel Debby; van Meurs Marjan; Melief Marie-José; Zähringer Ulrich; van Strijp Jos; Lambrecht Bart N; Nieuwenhuis Edward E; Laman Jon D
Proinflammatory bacterial peptidoglycan as a cofactor for the development of central nervous system autoimmune disease.
Journal of immunology (Baltimore, Md. : 1950) 2005;174(2):808-16.
2004: de Vos Alex F; Melief Marie-José; van Riel Debby; Boon Louis; van Eijk Marco; de Boer Mark; Laman Jon D
Antagonist anti-human CD40 antibody inhibits germinal center formation in cynomolgus monkeys.
European journal of immunology 2004;34(12):3446-55.
2004: 't Hart Bert A; Laman Jon D; Bauer Jan; Blezer Erwin; van Kooyk Yvette; Hintzen Rogier Q
Modelling of multiple sclerosis: lessons learned in a non-human primate.
Lancet neurology 2004;3(10):588-97.
2004: Gosselink Martijn P; Schouten W Rudolph; van Lieshout Leo M C; Hop Willem C J; Laman Jon D; Ruseler-van Embden Johanneke G H
Eradication of pathogenic bacteria and restoration of normal pouch flora: comparison of metronidazole and ciprofloxacin in the treatment of pouchitis.
Diseases of the colon and rectum 2004;47(9):1519-25.
2004: Boven Leonie A; van Meurs Marjan; Boot Rolf G; Mehta Atul; Boon Louis; Aerts Johannes M; Laman Jon D
Gaucher cells demonstrate a distinct macrophage phenotype and resemble alternatively activated macrophages.
American journal of clinical pathology 2004;122(3):359-69.
2004: Kuiken Thijs; van den Hoogen Bernadette G; van Riel Debby A J; Laman Jon D; van Amerongen Geert; Sprong Leo; Fouchier Ron A M; Osterhaus Albert D M E
Experimental human metapneumovirus infection of cynomolgus macaques (Macaca fascicularis) results in virus replication in ciliated epithelial cells and pneumocytes with associated lesions throughout the respiratory tract.
The American journal of pathology 2004;164(6):1893-900.
2004: Gosselink Martijn P; Schouten W Rudolph; van Lieshout Leo M C; Hop Willem C J; Laman Jon D; Ruseler-van Embden Johanneke G H
Delay of the first onset of pouchitis by oral intake of the probiotic strain Lactobacillus rhamnosus GG.
Diseases of the colon and rectum 2004;47(6):876-84.
2004: Geleijns Karin; Jacobs Bart C; Van Rijs Wouter; Tio-Gillen Anne P; Laman Jon D; van Doorn Pieter A
Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients.
Journal of neuroimmunology 2004;150(1-2):132-8.
2004: Ruseler-van Embden J G H; van Lieshout L M C; Smits S A; van Kessel I; Laman J D
Potato tuber proteins efficiently inhibit human faecal proteolytic activity: implications for treatment of peri-anal dermatitis.
European journal of clinical investigation 2004;34(4):303-11.
2004: Nijhuis Manon M Oude; van der Graaf Yolanda; Melief Marie-José; Schoneveld Arjan H; de Kleijn Dominique P V; Laman Jon D; Pasterkamp Gerard;
IgM antibody level against proinflammatory bacterial peptidoglycan is inversely correlated with extent of atherosclerotic disease.
Atherosclerosis 2004;173(2):245-51.
2004: Ang C Wim; Jacobs Bart C; Laman Jon D
The Guillain-Barré syndrome: a true case of molecular mimicry.
Trends in immunology 2004;25(2):61-6.
2004: van der Fits Leslie; van der Wel Leontine I; Laman Jon D; Prens Errol P; Verschuren Martie C M
In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
The Journal of investigative dermatology 2004;122(1):51-60.
2004: Boot Rolf G; Verhoek Marri; de Fost Maaike; Hollak Carla E M; Maas Mario; Bleijlevens Boris; van Breemen Marielle J; van Meurs Marjan; Boven Leonie A; Laman Jon D; Moran Mary Teresa; Cox Timothy M; Aerts Johannes M F G
Marked elevation of the chemokine CCL18/PARC in Gaucher disease: a novel surrogate marker for assessing therapeutic intervention.
Blood 2004;103(1):33-9.
2003: Maassen Catharina B M; Laman Jon D; van Holten-Neelen Conny; Hoogteijling Linsy; Groenewegen Lizet; Visser Lizette; Schellekens Marc M; Boersma Wim J A; Claassen Eric
Reduced experimental autoimmune encephalomyelitis after intranasal and oral administration of recombinant lactobacilli expressing myelin antigens.
Vaccine 2003;21(32):4685-93.
2003: Kuiken Thijs; Fouchier Ron A M; Schutten Martin; Rimmelzwaan Guus F; van Amerongen Geert; van Riel Debby; Laman Jon D; de Jong Ton; van Doornum Gerard; Lim Wilina; Ling Ai Ee; Chan Paul K S; Tam John S; Zambon Maria C; Gopal Robin; Drosten Christian; van der Werf Sylvie; Escriou Nicolas; Manuguerra Jean-Claude; Stöhr Klaus; Peiris J S Malik; Osterhaus Albert D M E
Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome.
Lancet 2003;362(9380):263-70.
2003: Maassen Catharina B M; Boersma Wim J A; van Holten-Neelen Conny; Claassen Eric; Laman Jon D
Growth phase of orally administered Lactobacillus strains differentially affects IgG1/IgG2a ratio for soluble antigens: implications for vaccine development.
Vaccine 2003;21(21-22):2751-7.
2003: Tang T J; Kwekkeboom J; Laman J D; Niesters H G M; Zondervan P E; de Man R A; Schalm S W; Janssen H L A
The role of intrahepatic immune effector cells in inflammatory liver injury and viral control during chronic hepatitis B infection.
Journal of viral hepatitis 2003;10(3):159-67.
2003: Laman Jon D; Leenen Pieter J M; Annels Nicola E; Hogendoorn Pancras C W; Egeler R Maarten
Langerhans-cell histiocytosis 'insight into DC biology'.
Trends in immunology 2003;24(4):190-6.
2003: van der Fits Leslie; van der Wel Leontine I; Laman Jon D; Prens Errol P; Verschuren Martie C M
Psoriatic lesional skin exhibits an aberrant expression pattern of interferon regulatory factor-2 (IRF-2).
The Journal of pathology 2003;199(1):107-14.
2002: Brok Herbert P M; van Meurs Marjan; Blezer Erwin; Schantz Allen; Peritt David; Treacy George; Laman Jon D; Bauer Jan; 't Hart Bert A
Prevention of experimental autoimmune encephalomyelitis in common marmosets using an anti-IL-12p40 monoclonal antibody.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(11):6554-63.
2002: de Vos Alex F; van Meurs Marjan; Brok Herbert P; Boven Leonie A; Hintzen Rogier Q; van der Valk Paul; Ravid Rivka; Rensing Susanne; Boon Louis; 't Hart Bert A; Laman Jon D
Transfer of central nervous system autoantigens and presentation in secondary lymphoid organs.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(10):5415-23.
2002: Visser Lizette; de Vos Alex F; Hamann Jörg; Melief Marie-José; van Meurs Marjan; van Lier René A W; Laman Jon D; Hintzen Rogier Q
Expression of the EGF-TM7 receptor CD97 and its ligand CD55 (DAF) in multiple sclerosis.
Journal of neuroimmunology 2002;132(1-2):156-63.
2002: Ang C W; Noordzij P G; de Klerk M A; Endtz H P; van Doorn P A; Laman J D
Ganglioside mimicry of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity in rabbits.
Infection and immunity 2002;70(9):5081-5.
2002: Laman Jon D; 't Hart Bert A; Brok Herbert; Meurs Marjan van; Schellekens Marc M; Kasran Ahmad; Boon Louis; Bauer Jan; Boer Mark de; Ceuppens Jan
Protection of marmoset monkeys against EAE by treatment with a murine antibody blocking CD40 (mu5D12).
European journal of immunology 2002;32(8):2218-28.
2002: Laman Jon D; Schoneveld Arjan H; Moll Frans L; van Meurs Marjan; Pasterkamp Gerard
Significance of peptidoglycan, a proinflammatory bacterial antigen in atherosclerotic arteries and its association with vulnerable plaques.
The American journal of cardiology 2002;90(2):119-23.
2002: Companjen Arjen R; van der Wel Leontine I; Boon Louis; Prens Errol P; Laman Jon D
CD40 ligation-induced cytokine production in human skin explants is partly mediated via IL-1.
International immunology 2002;14(6):669-76.
2002: Boon Louis; Laman Jon D; Ortiz-Buijsse Antonio; den Hartog Marcel T; Hoffenberg Simon; Liu Patrick; Shiau Fred; de Boer Mark
Preclinical assessment of anti-CD40 Mab 5D12 in cynomolgus monkeys.
Toxicology 2002;174(1):53-65.
2002: Buljevac D; Flach H Z; Hop W C J; Hijdra D; Laman J D; Savelkoul H F J; van Der Meché F G A; van Doorn P A; Hintzen R Q
Prospective study on the relationship between infections and multiple sclerosis exacerbations.
Brain : a journal of neurology 2002;125(Pt 5):952-60.
2002: Ang C W; Laman J D; Willison H J; Wagner E R; Endtz H P; De Klerk M A; Tio-Gillen A P; Van den Braak N; Jacobs B C; Van Doorn P A
Structure of Campylobacter jejuni lipopolysaccharides determines antiganglioside specificity and clinical features of Guillain-Barré and Miller Fisher patients.
Infection and immunity 2002;70(3):1202-8.
2001: Brok H P; Bauer J; Jonker M; Blezer E; Amor S; Bontrop R E; Laman J D; 't Hart B A
Non-human primate models of multiple sclerosis.
Immunological reviews 2001;183():173-85.
2001: Laman J D; Visser L; Maassen C B; de Groot C J; de Jong L A; 't Hart B A; van Meurs M; Schellekens M M
Novel monoclonal antibodies against proteolipid protein peptide 139-151 demonstrate demyelination and myelin uptake by macrophages in MS and marmoset EAE lesions.
Journal of neuroimmunology 2001;119(1):124-30.
2001: Boon L; Brok H P; Bauer J; Ortiz-Buijsse A; Schellekens M M; Ramdien-Murli S; Blezer E; van Meurs M; Ceuppens J; de Boer M; 't Hart B A; Laman J D
Prevention of experimental autoimmune encephalomyelitis in the common marmoset (Callithrix jacchus) using a chimeric antagonist monoclonal antibody against human CD40 is associated with altered B cell responses.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(5):2942-9.
2001: Schrijver I A; van Meurs M; Melief M J; Wim Ang C; Buljevac D; Ravid R; Hazenberg M P; Laman J D
Bacterial peptidoglycan and immune reactivity in the central nervous system in multiple sclerosis.
Brain : a journal of neurology 2001;124(Pt 8):1544-54.
2001: Companjen A R; van der Wel L I; Wei L; Laman J D; Prens E P
A modified ex vivo skin organ culture system for functional studies.
Archives of dermatological research 2001;293(4):184-90.
2001: Schrijver I A; Melief M J; Markusse H M; Van Aelst I; Opdenakker G; Hazenberg M P; Laman J D
Peptidoglycan from sterile human spleen induces T-cell proliferation and inflammatory mediators in rheumatoid arthritis patients and healthy subjects.
Rheumatology (Oxford, England) 2001;40(4):438-46.
2001: Ang C W; De Klerk M A; Endtz H P; Jacobs B C; Laman J D; van der Meché F G; van Doorn P A
Guillain-Barré syndrome- and Miller Fisher syndrome-associated Campylobacter jejuni lipopolysaccharides induce anti-GM1 and anti-GQ1b Antibodies in rabbits.
Infection and immunity 2001;69(4):2462-9.
2001: Schrijver I A; De Man Y A; Melief M J; Van Laar J M; Markusse H M; Klasen I S; Hazenberg M P; Laman J D
Reduced systemic IgG levels against peptidoglycan in rheumatoid arthritis (RA) patients.
Clinical and experimental immunology 2001;123(1):140-6.
2000: Egeler R M; Favara B E; Laman J D; Claassen E
Abundant expression of CD40 and CD40-ligand (CD154) in paediatric Langerhans cell histiocytosis lesions.
European journal of cancer (Oxford, England : 1990) 2000;36(16):2105-10.
2000: Schrijver I A; Melief M J; Tak P P; Hazenberg M P; Laman J D
Antigen-presenting cells containing bacterial peptidoglycan in synovial tissues of rheumatoid arthritis patients coexpress costimulatory molecules and cytokines.
Arthritis and rheumatism 2000;43(10):2160-8.
2000: Huisman J G; Carotenuto A; Labrijn A F; Papavoine C H; Laman J D; Schellekens M M; Koppelman M H; Hilbers C W
Recognition properties of V3-specific antibodies to V3 loop peptides derived from HIV-1 gp120 presented in multiple conformations.
Biochemistry 2000;39(35):10866-76.
2000: Brok H P; Uccelli A; Kerlero De Rosbo N; Bontrop R E; Roccatagliata L; de Groot N G; Capello E; Laman J D; Nicolay K; Mancardi G L; Ben-Nun A; Hart B A
Myelin/oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis in common marmosets: the encephalitogenic T cell epitope pMOG24-36 is presented by a monomorphic MHC class II molecule.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(2):1093-101.
2000: 't Hart B A; van Meurs M; Brok H P; Massacesi L; Bauer J; Boon L; Bontrop R E; Laman J D
A new primate model for multiple sclerosis in the common marmoset.
Immunology today 2000;21(6):290-7.
2000: Maassen C B; van Holten-Neelen C; Balk F; den Bak-Glashouwer M J; Leer R J; Laman J D; Boersma W J; Claassen E
Strain-dependent induction of cytokine profiles in the gut by orally administered Lactobacillus strains.
Vaccine 2000;18(23):2613-23.
2000: Ang C W; Endtz H P; Jacobs B C; Laman J D; de Klerk M A; van der Meché F G; van Doorn P A
Campylobacter jejuni lipopolysaccharides from Guillain-Barré syndrome patients induce IgG anti-GM1 antibodies in rabbits.
Journal of neuroimmunology 2000;104(2):133-8.
2000: Ang C W; Jacobs B C; Brandenburg A H; Laman J D; van der Meché F G; Osterhaus A D; van Doorn P A
Cross-reactive antibodies against GM2 and CMV-infected fibroblasts in Guillain-Barré syndrome.
Neurology 2000;54(7):1453-8.
2000: Schrijver I A; Melief M J; van Meurs M; Companjen A R; Laman J D
Pararosaniline fixation for detection of co-stimulatory molecules, cytokines, and specific antibody.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 2000;48(1):95-103.
1999: Egeler R M; Favara B E; van Meurs M; Laman J D; Claassen E
Differential In situ cytokine profiles of Langerhans-like cells and T cells in Langerhans cell histiocytosis: abundant expression of cytokines relevant to disease and treatment.
Blood 1999;94(12):4195-201.
1999: ten Bokum A M; Hofland L J; de Jong G; Bouma J; Melief M J; Kwekkeboom D J; Schonbrunn A; Mooy C M; Laman J D; Lamberts S W; van Hagen P M
Immunohistochemical localization of somatostatin receptor sst2A in sarcoid granulomas.
European journal of clinical investigation 1999;29(7):630-6.
1999: Schrijver I A; Melief M J; Eulderink F; Hazenberg M P; Laman J D
Bacterial peptidoglycan polysaccharides in sterile human spleen induce proinflammatory cytokine production by human blood cells.
The Journal of infectious diseases 1999;179(6):1459-68.
1999: Maassen C B; Laman J D; den Bak-Glashouwer M J; Tielen F J; van Holten-Neelen J C; Hoogteijling L; Antonissen C; Leer R J; Pouwels P H; Boersma W J; Shaw D M
Instruments for oral disease-intervention strategies: recombinant Lactobacillus casei expressing tetanus toxin fragment C for vaccination or myelin proteins for oral tolerance induction in multiple sclerosis.
Vaccine 1999;17(17):2117-28.
1999: Kuipers M E; vd Berg M; Swart P J; Laman J D; Meijer D K; Koppelman M H; Huisman H
Mechanism of anti-HIV activity of succinylated human serum albumin.
Biochemical pharmacology 1999;57(8):889-98.
1998: Laman J D; Thompson E J; Kappos L
Balancing the Th1/Th2 concept in multiple sclerosis.
Immunology today 1998;19(11):489-90.
1998: Laman J D; Thompson E J; Kappos L
Body fluid markers to monitor multiple sclerosis: the assays and the challenges.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):266-9.
1998: Laman J D; Maassen C B; Schellekens M M; Visser L; Kap M; de Jong E; van Puijenbroek M; van Stipdonk M J; van Meurs M; Schwärzler C; Günthert U
Therapy with antibodies against CD40L (CD154) and CD44-variant isoforms reduces experimental autoimmune encephalomyelitis induced by a proteolipid protein peptide.
Multiple sclerosis (Houndmills, Basingstoke, England) 1998;4(3):147-53.
1998: Laman J D; van Meurs M; Schellekens M M; de Boer M; Melchers B; Massacesi L; Lassmann H; Claassen E; Hart B A
Expression of accessory molecules and cytokines in acute EAE in marmoset monkeys (Callithrix jacchus).
Journal of neuroimmunology 1998;86(1):30-45.
1998: Günthert U; Schwärzler C; Wittig B; Laman J; Ruiz P; Stauder R; Bloem A; Smadja-Joffe F; Zöller M; Rolink A
Functional involvement of CD44, a family of cell adhesion molecules, in immune responses, tumour progression and haematopoiesis.
Advances in experimental medicine and biology 1998;451():43-9.
1998: Laman J D; De Boer M; Hart B A
CD40 in clinical inflammation: from multiple sclerosis to atherosclerosis.
Developmental immunology 1998;6(3-4):215-22.
1998: Maassen C B; van Holten J C; Balk F; Heijne den Bak-Glashouwer M J; Leer R; Laman J D; Boersma W J; Claassen E
Orally administered Lactobacillus strains differentially affect the direction and efficacy of the immune response.
The Veterinary quarterly 1998;20 Suppl 3():S81-3.
1997: Laman J D; de Smet B J; Schoneveld A; van Meurs M
CD40-CD40L interactions in atherosclerosis.
Immunology today 1997;18(6):272-7.
1996: Green K A; Crassi K M; Laman J D; Schoneveld A; Strawbridge R R; Foy T M; Noelle R J; Green W R
Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.
Journal of virology 1996;70(4):2569-75.
1996: Gerritse K; Laman J D; Noelle R J; Aruffo A; Ledbetter J A; Boersma W J; Claassen E
CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis.
Proceedings of the National Academy of Sciences of the United States of America 1996;93(6):2499-504.
1996: Laman J D; Claassen E; Noelle R J
Functions of CD40 and its ligand, gp39 (CD40L).
Critical reviews in immunology 1996;16(1):59-108.
1995: Bogers W M; Niphuis H; ten Haaft P; Laman J D; Koornstra W; Heeney J L
Protection from HIV-1 envelope-bearing chimeric simian immunodeficiency virus (SHIV) in rhesus macaques infected with attenuated SIV: consequences of challenge.
AIDS (London, England) 1995;9(12):F13-8.
1995: Foy T M; Page D M; Waldschmidt T J; Schoneveld A; Laman J D; Masters S R; Tygrett L; Ledbetter J A; Aruffo A; Claassen E; Xu J C; Flavell R A; Oehen S; Hedrick S M; Noelle R J
An essential role for gp39, the ligand for CD40, in thymic selection.
The Journal of experimental medicine 1995;182(5):1377-88.
1994: van den Eertwegh A J; Laman J D; Noelle R J; Boersma W J; Claassen E
In vivo T-B cell interactions and cytokine-production in the spleen.
Seminars in immunology 1994;6(5):327-36.
1994: Durie F H; Foy T M; Masters S R; Laman J D; Noelle R J
The role of CD40 in the regulation of humoral and cell-mediated immunity.
Immunology today 1994;15(9):406-11.
1994: Xu J; Foy T M; Laman J D; Elliott E A; Dunn J J; Waldschmidt T J; Elsemore J; Noelle R J; Flavell R A
Mice deficient for the CD40 ligand.
Immunity 1994;1(5):423-31.
1994: Laman J D; Claassen E; Noelle R J
Immunodeficiency due to a faulty interaction between T cells and B cells.
Current opinion in immunology 1994;6(4):636-41.
1994: Foy T M; Laman J D; Ledbetter J A; Aruffo A; Claassen E; Noelle R J
gp39-CD40 interactions are essential for germinal center formation and the development of B cell memory.
The Journal of experimental medicine 1994;180(1):157-63.
1994: Abacioglu Y H; Fouts T R; Laman J D; Claassen E; Pincus S H; Moore J P; Roby C A; Kamin-Lewis R; Lewis G K
Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
AIDS research and human retroviruses 1994;10(4):371-81.
1993: Laman J D; Schellekens M M; Lewis G K; Moore J P; Matthews T J; Langedijk J P; Meloen R H; Boersma W J; Claassen E
A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody.
AIDS research and human retroviruses 1993;9(7):605-12.
1993: Laman J D; Schellekens M M; Paddenburg D; Tersmette M; Langedijk J P; Boersma W J; Claassen E
HIV-1-specific polyclonal and monoclonal antibodies raised with synthetic peptides: characterization and applications.
The Year in immunology 1993;7():63-8.
1993: Claassen E; Zegers N D; Laman J D; Boersma W J
Use of synthetic peptides for the production of site (amino acid) specific polyclonal and monoclonal antibodies.
The Year in immunology 1993;7():150-61.
1992: Laman J D; Schellekens M M; Abacioglu Y H; Lewis G K; Tersmette M; Fouchier R A; Langedijk J P; Claasen E; Boersma W J
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
Journal of virology 1992;66(8):5175.
1992: Claassen E; Gerritse K; Laman J D; Boersma W J
New immunoenzyme-cytochemical stainings for the in situ detection of epitope specificity and isotype of antibody forming B cells in experimental and natural (auto) immune responses in animals and man.
Journal of immunological methods 1992;150(1-2):207-16.
1992: Laman J D; Schellekens M M; Abacioglu Y H; Lewis G K; Tersmette M; Fouchier R A; Langedijk J P; Claassen E; Boersma W J
Variant-specific monoclonal and group-specific polyclonal human immunodeficiency virus type 1 neutralizing antibodies raised with synthetic peptides from the gp120 third variable domain.
Journal of virology 1992;66(3):1823-31.
1992: Laman J D; van den Eertwegh A J
Cytotoxic potential of CD8+ T-cells in lymphoid follicles during HIV-1 infection.
AIDS (London, England) 1992;6(3):333-5.
1992: van den Eertwegh A J; Laman J D; Schellekens M M; Boersma W J; Claassen E
Complement-mediated follicular localization of T-independent type-2 antigens: the role of marginal zone macrophages revisited.
European journal of immunology 1992;22(3):719-26.
1992: Laman J D; ter Hart H; Boorsma D M; Claassen E; Van Rooijen N
Production of monomeric antigen-enzyme conjugate to study requirements for follicular immune complex trapping.
Histochemistry 1992;97(2):189-94.
1991: Laman J D; van den Eertwegh A J; Deen C; Vermeulen N; Boersma W J; Claassen E
Synthetic peptide conjugates with horseradish peroxidase and beta-galactosidase for use in epitope-specific immunocytochemistry and ELISA.
Journal of immunological methods 1991;145(1-2):1-10.
1991: Laman J D; Rácz P; Tenner-Rácz K; Klasmeier M; Fasbender M J; Neelen C; Zegers N D; Dietrich M; Boersma W J; Claassen E
Immunocytochemical determination of antigen and epitope specificity of HIV-1-specific B cells in lymph-node biopsies from HIV-1-infected individuals.
AIDS (London, England) 1991;5(3):255-62.
1991: Laman J D; Kors N; Heeney J L; Boersma W J; Claassen E
Fixation of cryo-sections under HIV-1 inactivating conditions: integrity of antigen binding sites and cell surface antigens.
Histochemistry 1991;96(2):177-83.
1990: Laman J D; Kors N; Van Rooijen N; Claassen E
Mechanism of follicular trapping: localization of immune complexes and cell remnants after elimination and repopulation of different spleen cell populations.
Immunology 1990;71(1):57-62.
1990: Laman J D; Gerritse K; Fasbender M; Boersma W J; van Rooijen N; Claassen E
Double immunocytochemical staining for in vivo detection of epitope specificity and isotype of antibody-forming cells against synthetic peptides homologous to human immunodeficiency virus-1.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society 1990;38(4):457-62.
1989: Laman J D; Claassen E; Van Rooijen N; Boersma W J
Immune complexes on follicular dendritic cells as a target for cytolytic cells in AIDS.
AIDS (London, England) 1989;3(8):543-4.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Jon Laman

Research Profile (preview)

Disorders

Living Beings

Chemicals & Drugs

Procedures

Anatomy

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Jon Laman (preview)

All Publications